Grunberg Gregory 4
4 · Kala Pharmaceuticals, Inc. · Filed Oct 9, 2018
Insider Transaction Report
Form 4
Grunberg Gregory
Director10% Owner
Transactions
- Purchase
Common Stock
2018-10-05$8.25/sh+606,060$4,999,995→ 2,877,006 total(indirect: By Longitude Venture Partners II, L.P.)
Footnotes (1)
- [F1]These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.